EXOMIND is a groundbreaking FDA-cleared mental wellness device developed by BTL, built on decades of well-researched Transcranial Magnetic Stimulation (TMS) technology and equipped with proprietary ExoTMS™ innovation. It delivers non-invasive, drug-free neuromodulation therapy primarily indicated for Major Depressive Disorder (MDD). Serving as a reliable alternative for patients who see little improvement from antidepressants, counseling or traditional therapies, EXOMIND recalibrates brain neural circuits to lift low mood, restore cognitive control and rebuild long-term mental balance. It is widely adopted by psychiatrists, family physicians and aesthetic clinics for integrated physical and mental wellness care.